VJHemOnc is committed to improving our service to you

IMW 2019 | Maintaining MM CAR T-cell therapy response

VJHemOnc is committed to improving our service to you

Niels van de Donk

Niels van de Donk, MD, PhD, from VU University Medical Center, Amsterdam, The Netherlands, explains how we can maintain CAR T-cell therapy responses in the myeloma space. This interview was speaking at the International Myeloma Workshop (IMW) 2019, held in Boston, MA.

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter